Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer

Go back to Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
(NASDAQ: DNLI) Delayed: 22.56 -0.29 (1.27%)
Previous Close $22.85    52 Week High
Open $23.00    52 Week Low
Day High $23.03    P/E N/A 
Day Low $22.35    EPS
Volume 1,088,103